Paper Details

  1. Home
  2. Paper Details

Antiviral Activity of the Propylamylatin<sup>TM</sup> Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions.

Author: BrownAshley N, HanrahanKaley C, SearsJoe, StrobelGary

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A Propylamylatin formula, a mixture of propionic acid and isoamyl hexanoates, showed antiviral activity against SARS-CoV-2. The formula effectively inactivated infectious SARS-CoV-2 to undetectable levels in both gaseous and liquid phases. The combination of propionic acid and isoamyl hexanoates was more potent than the individual components alone, suggesting a potential therapeutic strategy for COVID-19.
Paper Details　
Original Abstract of the Article :
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of novel coronavirus disease 2019 (COVID-19), has become a severe threat to global public health. There are currently no antiviral therapies approved for the treatment or prevention of mild to moderate COVID-19 as remd...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999574/

データ提供：米国国立医学図書館（NLM）

Antiviral Activity of the PropylamylatinTM Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions

This research investigates the antiviral potential of a Propylamylatin formula against the novel coronavirus, SARS-CoV-2. Imagine the Propylamylatin formula as a powerful weapon in the battle against the COVID-19 desert, capable of inactivating the virus and potentially offering a new line of defense against this global threat. The authors tested the formula in both gaseous and liquid phases, finding that it effectively inactivated SARS-CoV-2, suggesting a potential therapeutic strategy for treating COVID-19. This is a groundbreaking discovery, potentially offering a new oasis in the arid landscape of COVID-19 treatment options.

Propylamylatin Formula: A Potential Weapon Against SARS-CoV-2

This research presents a promising antiviral agent, Propylamylatin, which shows potential in combating SARS-CoV-2. This could be a game-changer in the fight against COVID-19, offering a new pathway for treatment and prevention.

A New Hope in the COVID-19 Desert

The discovery of Propylamylatin's antiviral activity is a beacon of hope in the COVID-19 desert. It offers a potential new line of defense against this global pandemic, providing a much-needed oasis in the arid landscape of COVID-19 treatment options. This research is a testament to the ongoing efforts of scientists to develop effective treatments and ultimately conquer this pandemic.

Dr.Camel's Conclusion

This research provides a glimmer of hope in the COVID-19 desert, showcasing the antiviral potential of the Propylamylatin formula. This could be a game-changer in the fight against SARS-CoV-2, offering a potential treatment and prevention strategy.

Date :
  1. Date Completed 2021-04-19
  2. Date Revised 2021-04-19
Further Info :

Pubmed ID

33807769

DOI: Digital Object Identifier

PMC7999574

Related Literature

Article Analysis
・Effects of remdesivir injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.